Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kern

Showing results (531-540 of 555) with videos related to

Pageof 56
Sort By:
Critical Reviews in Toxicology|February 24, 2018
Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup/>Sebastian Hoffmann, Nicole Kleinstreuer, Nathalie Alépée, et al.
The Journal of Investigative Dermatology|December 26, 2025
A transgenic mouse allows characterisation of the HLA-C*06:02 immunopeptidome in a model of psoriasisAsolina Braun, Jesse I Mobbs, Shanzou Chung, et al.
JAMA Network Open|September 2, 2021
Evaluation of an Educational Outreach and Audit and Feedback Program to Reduce Continuous Pulse Oximetry Use in Hospitalized Infants With Stable Bronchiolitis: A Nonrandomized Clinical TrialAmanda C Schondelmeyer, Amanda P Bettencourt, Rui Xiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibitionJennings C Luu, Aicha Saadane, Henri Leinonen, et al.
Schizophrenia Research|August 20, 2018
Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophreniaPeter E Clayson, Robert S Kern, Keith H Nuechterlein, et al.
The British Journal of Dermatology|July 14, 2017
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysisT Schmidt, M Hoch, S S Lotfi Jad, et al.
Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersConor Fearon, Sapna Rawal, Diana Olszewska, et al.
Lancet (London, England)|November 28, 2025
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trialsEmma Guttman-Yassky, Kenji Kabashima, Margitta Worm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's diseaseNaomi P Visanji, Grace S Bhudhikanok, Tiago A Mestre, et al.
Pageof 56

Showing results (531-540 of 555) with videos related to

Sort By:
Pageof 56
Critical Reviews in Toxicology|February 24, 2018
Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup/>Sebastian Hoffmann, Nicole Kleinstreuer, Nathalie Alépée, et al.
The Journal of Investigative Dermatology|December 26, 2025
A transgenic mouse allows characterisation of the HLA-C*06:02 immunopeptidome in a model of psoriasisAsolina Braun, Jesse I Mobbs, Shanzou Chung, et al.
JAMA Network Open|September 2, 2021
Evaluation of an Educational Outreach and Audit and Feedback Program to Reduce Continuous Pulse Oximetry Use in Hospitalized Infants With Stable Bronchiolitis: A Nonrandomized Clinical TrialAmanda C Schondelmeyer, Amanda P Bettencourt, Rui Xiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibitionJennings C Luu, Aicha Saadane, Henri Leinonen, et al.
Schizophrenia Research|August 20, 2018
Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophreniaPeter E Clayson, Robert S Kern, Keith H Nuechterlein, et al.
The British Journal of Dermatology|July 14, 2017
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysisT Schmidt, M Hoch, S S Lotfi Jad, et al.
Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.
Movement Disorders Clinical Practice|April 11, 2022
Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersConor Fearon, Sapna Rawal, Diana Olszewska, et al.
Lancet (London, England)|November 28, 2025
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trialsEmma Guttman-Yassky, Kenji Kabashima, Margitta Worm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's diseaseNaomi P Visanji, Grace S Bhudhikanok, Tiago A Mestre, et al.
Pageof 56